Reuters logo
Johnson & Johnson expects to complete of Actelion offer on June 16
June 9, 2017 / 4:03 PM / 6 months ago

Johnson & Johnson expects to complete of Actelion offer on June 16

ZURICH (Reuters) - Johnson & Johnson (JNJ.N) said Friday’s approval of its proposed acquisition of Swiss biotech company Actelion ATLN.S by the European Commission meant all regulatory approvals required to complete the $30 billion deal have been received.

    The U.S. company said it expects settlement of the all-cash public tender offer by its Swiss subsidiary, Janssen Holding, on June 16.

    EU antitrust regulators approved on Friday Johnson & Johnson’s planned purchase of Actelion subject to conditions intended to ensure clinical development of insomnia drugs were unaffected.

    Reporting by John Revill; editing by Brenna Hughes Neghaiwi

    0 : 0
    • narrow-browser-and-phone
    • medium-browser-and-portrait-tablet
    • landscape-tablet
    • medium-wide-browser
    • wide-browser-and-larger
    • medium-browser-and-landscape-tablet
    • medium-wide-browser-and-larger
    • above-phone
    • portrait-tablet-and-above
    • above-portrait-tablet
    • landscape-tablet-and-above
    • landscape-tablet-and-medium-wide-browser
    • portrait-tablet-and-below
    • landscape-tablet-and-below